Evidence for multiple peroxisome proliferator-activated receptor gamma transcripts in bone: fine-tuning by hormonal regulation and mRNA stability

FEBS Lett. 2008 May 14;582(11):1618-24. doi: 10.1016/j.febslet.2008.04.012. Epub 2008 Apr 22.

Abstract

The expression, regulation and functional significance of multiple peroxisome proliferator-activated receptor gamma transcript variants in bone were studied. PPARG transcripts giving rise to PPARg-1 protein were expressed in human osteoblasts, whereas PPARG-2 transcript and protein remained virtually absent. PPARG expression underwent homologous regulation, was upregulated during differentiation and directly induced by the osteogenic hormone dexamethasone, suggesting a role for PPARg-1 in osteogenesis. Differences between the stabilities of PPARG-1, -3 and -4 were observed. We hypothesize that cell-specific expression patterns of multiple PPARG transcript variants encoding for the same protein but differing in mRNA stabilities enable a fine-tuning of PPARG action, which eventually supports a well-adjusted signal transduction between the cell and its environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alternative Splicing
  • Bone and Bones / cytology
  • Bone and Bones / drug effects
  • Bone and Bones / metabolism*
  • Cell Differentiation / drug effects
  • Cell Line
  • Dexamethasone / pharmacology
  • Gene Expression Regulation*
  • Humans
  • Osteoblasts / cytology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism
  • PPAR gamma / agonists
  • PPAR gamma / genetics*
  • RNA Stability*
  • RNA, Messenger / metabolism*
  • Rosiglitazone
  • Thiazolidinediones / pharmacology
  • Transcription, Genetic / drug effects

Substances

  • PPAR gamma
  • RNA, Messenger
  • Thiazolidinediones
  • Rosiglitazone
  • Dexamethasone